These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7983955)

  • 1. Cellular immune response to common mycobacterial antigens in subjects seropositive for Trypanosoma cruzi.
    Bottasso OA; Ingledew N; Keni M; Morini J; Pividori JF; Rook GA; Stanford JL
    Lancet; 1994 Dec; 344(8936):1540-1. PubMed ID: 7983955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.
    Cetron MS; Basilio FP; Moraes AP; Sousa AQ; Paes JN; Kahn SJ; Wener MH; Van Voorhis WC
    Am J Trop Med Hyg; 1993 Sep; 49(3):370-82. PubMed ID: 8372959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of delayed-type hypersensitivity to Trypanosoma cruzi in mice treated with Mycobacterium bovis BCG and cyclophosphamide.
    Abrahamsohn IA; Blotta MH; Curotto MA
    Infect Immun; 1981 Mar; 31(3):1145-51. PubMed ID: 6785239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma cruzi: identification of specific epimastigote antigens by human immune sera.
    Morgado MG; Ivo-dos-Santos J; Pinho RT; Argüelles E; Rezende JM; Galvão-Castro B
    Mem Inst Oswaldo Cruz; 1989; 84(3):309-14. PubMed ID: 2485213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated reactivity against human and Trypanosoma cruzi antigens according to clinical status in Chagas' disease patients.
    De Titto EH; Braun M; Lazzari JO; Segura EL
    Immunol Lett; 1985; 9(5):249-54. PubMed ID: 3922879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Chagas' disease: evolution of the antibody response and recognition of antigens of Trypanosoma cruzi.
    Araujo FG; Israelski DM; de Titto EH
    Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():522-6. PubMed ID: 3151007
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of the cellular immune response in Chagas' disease patients.
    Castes M; Araujo Z; Mosca W
    Acta Cient Venez; 1986; 37(5):547-53. PubMed ID: 3129894
    [No Abstract]   [Full Text] [Related]  

  • 9. Acquired cell-mediated immunodepression in acute Chagas' disease.
    Teixeira AR; Teixeira G; Macêdo V; Prata A
    J Clin Invest; 1978 Dec; 62(6):1132-41. PubMed ID: 107195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmunity in Chagas' disease: immunomodulation of autoimmune and T. cruzi-specific immune responses.
    Rizzo LV; Cunha-Neto E; Teixeira AR
    Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():360-2. PubMed ID: 3150998
    [No Abstract]   [Full Text] [Related]  

  • 11. Purified excreted-secreted antigens from Trypanosoma cruzi trypomastigotes as tools for diagnosis of Chagas' disease.
    Berrizbeitia M; Ndao M; Bubis J; Gottschalk M; Aché A; Lacouture S; Medina M; Ward BJ
    J Clin Microbiol; 2006 Feb; 44(2):291-6. PubMed ID: 16455872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chagas' disease: humoral response to subcellular fraction of Trypanosoma cruzi in symptomatic and asymptomatic patients.
    de Titto EH; Moreno M; Braun M; Segura EL
    Trop Med Parasitol; 1987 Sep; 38(3):163-6. PubMed ID: 3124252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypsin-treated and coomassie blue-stained epimastigote antigen in a microagglutination test for Chagas' disease.
    el Harith A; Laarman JJ; Minter-Goedbloed E; Kager PA; Kolk AH
    Am J Trop Med Hyg; 1987 Jul; 37(1):66-71. PubMed ID: 2440329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmunity in Chagas' disease.
    Kierszenbaum F
    J Parasitol; 1986 Apr; 72(2):201-11. PubMed ID: 3090218
    [No Abstract]   [Full Text] [Related]  

  • 15. Humoral autoimmune response in Chagas' disease: Trypanosoma cruzi ribosomal antigens as immunizing agents.
    Levin MJ; Kaplan D; Ferrari I; Arteman P; Vazquez M; Panebra A
    FEMS Immunol Med Microbiol; 1993 Oct; 7(3):205-10. PubMed ID: 7506093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific immunodiagnosis of Chagas disease: immunodiffusion test using a specific serum anti-Trypanosoma cruzi component 5.
    Breniere FS; Carlier Y; Carrasco R; Molinedo S; Lemesre JL; Desjeux P; Afchain D
    Trop Geogr Med; 1987 Jul; 39(3):281-6. PubMed ID: 3124314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell mediated immunity in Chagas' disease. Trypanosoma cruzi antigens induce suppression of the in vitro proliferative response of mononuclear cells.
    Mosca W; Briceño L; Hernández MI
    Mem Inst Oswaldo Cruz; 1991; 86(2):147-52. PubMed ID: 1842408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage.
    Di Noia JM; Buscaglia CA; De Marchi CR; Almeida IC; Frasch AC
    J Exp Med; 2002 Feb; 195(4):401-13. PubMed ID: 11854354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of cell-mediated immunity in experimental Chagas' disease.
    Reed SG; Larson CL; Speer CA
    Z Parasitenkd; 1977 Jun; 52(1):11-7. PubMed ID: 407736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chagas' disease: Trypanosoma cruzi vs. the host immune system.
    Hontebeyrie-Joskowicz M; Minoprio P
    Res Immunol; 1991 Feb; 142(2):125-6. PubMed ID: 1907752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.